Testing a program to help caregivers of children with sickle cell disease
Part of Blood & lymphatic, Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This trial tests a program called the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) that helps caregivers support the development of children with sickle cell disease. It includes all types of sickle cell disease and focuses on children up to 30 months old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are the caregiver of a child with sickle cell disease
- Your child is 30 months or younger (up to 30 months old)
- You are able to speak and understand English well
- Your child does not have other health conditions that cause developmental delays (besides sickle cell disease)
- Your child is not too medically fragile to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help preschoolers with sickle cell disease get ready for school. It looks at whether a special learning program can help with skills like paying attention and getting along with others.
This study tests a structured program to help teens with sickle cell disease smoothly transition from pediatric care to adult care, with support for parents or legal guardians. It may help families coordinate care sooner and more confidently during this change.
This study helps connect adults with sickle cell disease who haven't seen a specialist in over a year back into care. It tests a program designed to make it easier to get regular medical support and improve your health.
This study collects feedback through surveys, interviews, and focus groups from people affected by sickle cell disease. Your input helps the research team improve how genomic and gene-therapy information and needs are understood for patients and caregivers.
This trial tests a new treatment called CS-206 for adolescents with severe sickle cell disease. It aims to see if this treatment can help by making stem cell transplants safer and more effective for people who have not done well with standard care.
This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.